| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 128.989 | 294.435 | 1.135.848 |
| Total Income - EUR | - | - | - | - | - | - | - | 129.103 | 294.989 | 1.140.006 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 1.095 | 38.223 | 198.384 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 128.008 | 256.765 | 941.622 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 124.216 | 253.880 | 853.135 |
| Employees | - | - | - | - | - | - | - | 0 | 1 | 1 |
Check the financial reports for the company - Molecular Imaging Healthcare S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 69 | 566 | 66.648 |
| Current Assets | - | - | - | - | - | - | - | 127.345 | 264.944 | 1.849.105 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 111.773 | 151.808 | 772.753 |
| Cash | - | - | - | - | - | - | - | 15.572 | 113.136 | 1.076.352 |
| Shareholders Funds | - | - | - | - | - | - | - | 124.237 | 253.920 | 853.175 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 3.177 | 11.589 | 1.062.578 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Molecular Imaging Healthcare S.r.l.